Your browser doesn't support javascript.
loading
Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
Gebrie, Desye; Getnet, Desalegn; Manyazewal, Tsegahun.
Affiliation
  • Gebrie D; School of Pharmacy, College of Health Sciences, Mekelle University, Mekelle, Ethiopia. desye.gebrie@mu.edu.et.
  • Getnet D; Addis Ababa University, College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa, Ethiopia. desye.gebrie@mu.edu.et.
  • Manyazewal T; Pharmacology and Toxicology Course and Research Team, Department of Pharmacy, College of Health Sciences, Adigrat University, Adigrat, Ethiopia.
Sci Rep ; 11(1): 137, 2021 01 08.
Article in En | MEDLINE | ID: mdl-33420333

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonylurea Compounds / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Hypoglycemic Agents / Metformin Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Ethiopia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sulfonylurea Compounds / Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Hypoglycemic Agents / Metformin Type of study: Clinical_trials / Guideline / Systematic_reviews Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Sci Rep Year: 2021 Document type: Article Affiliation country: Ethiopia